Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 17:20:10 - browse：5588

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Adopting new red light myopia treatments may be short

hotspot

WSS

Devoted Health’s losses in Medicare Advantage persist

Adopting new red light myopia treatments may be short

Adopting new red light myopia treatments may be short

Padmanee Sharma of MD Anderson at center of lawsuit over credit

What’s missing from the debate over nursing home staff minimums

Global cancer cases to surge 77% by 2050, WHO report says

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A protest over insulin prices is seen as a fight for life

Medical records are filled with copy

U.K. decision on ALS drug has neurologists, advocates up in arms

Alkermes shareholders re

Adopting new red light myopia treatments may be short

At least 13 dead in Texas as scorching temps continue

Global cancer cases to surge 77% by 2050, WHO report says

What does generative AI mean for health care? We asked experts

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

entertainment

Harvard scientists, with Google, unveil the most detailed brain map ever

AstraZeneca stays mum on Medicare drug pricing negotiations

Trial using CRISPR to edit HIV out of cells disappoints

Bernie brings in new pharma CEOs to talk drug prices

Oral obesity drug from Viking Therapeutics hits key early target

People with mental disorders often marry others with same

focus

hotspot

Wikipedia

knowledge